4.6 Article

Investigating rutin as a potential transforming growth factor-β type I receptor antagonist for the inhibition of bleomycin-induced lung fibrosis

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Derrone Targeting the TGF Type 1 Receptor Kinase Improves Bleomycin-Mediated Pulmonary Fibrosis through Inhibition of Smad Signaling Pathway

Ilandarage Menu Neelaka Molagoda et al.

Summary: In this study, the anti-fibrotic effects of derrone on TGF-beta 1-stimulated MRC-5 lung fibroblast cells and bleomycin-induced lung fibrosis were investigated. It was found that high concentrations of derrone increased cytotoxicity in MRC-5 cells, but low concentrations did not induce significant cell death. Derrone reduced the expression of TGF-beta 1, fibronectin, elastin, and collagen1 alpha 1 in TGF-beta 1-stimulated MRC-5 cells, and also attenuated fibrotic histopathological changes in bleomycin-treated mice.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biology

Enzymatic Hydrolysis of Rutin: Evaluation of Kinetic Parameters and Anti-Proliferative, Mutagenic and Anti-Mutagenic Effects

Mariana Alves Sobreiro et al.

Summary: The bioavailability of glucoside flavonoids is affected by the nature of the sugar, with glucosides being absorbed faster than rhamnoglucosides. Enzymatic hydrolysis is a strategy to enhance bioavailability. This study evaluated the kinetic parameters of hesperidinase-mediated hydrolysis of rutin and found that hydrolyzed rutin derivatives showed anti-proliferative and anti-mutagenic effects, making it a promising raw material for food supplements.

LIFE-BASEL (2023)

Article Pharmacology & Pharmacy

Discovery of pulmonary fibrosis inhibitor targeting TGF-I3 RI in Polygonum cuspidatum by high resolution mass spectrometry with in silico strategy

Huarong Xu et al.

Summary: This study developed a new method using high resolution mass spectrometry and in silico strategy to search for potential chemical ingredients in Polygonum cuspidatum (PC) that target the TGF-I3 RI. Resveratrol, a compound found in PC, was identified to have excellent biological activity on TGF-I3 RI and potential as a treatment for PF.

JOURNAL OF PHARMACEUTICAL ANALYSIS (2022)

Review Biochemistry & Molecular Biology

Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis

Mahbub Hasan et al.

Summary: Pulmonary fibrosis is a disease that is difficult to treat, but natural products have shown potential in inhibiting inflammation, oxidative stress, and cell signaling for its treatment.

MOLECULES (2022)

Review Medicine, General & Internal

Interstitial lung diseases

Marlies Wijsenbeek et al.

Summary: There are over 200 recognized interstitial lung diseases, which vary in rarity. Most of these diseases are characterized by inflammation or fibrosis in the interstitial space, leading to impaired gas exchange and resulting in symptoms such as breathlessness, decreased exercise tolerance, and reduced quality of life. The prognosis for different interstitial lung diseases varies considerably, with some conditions showing reversibility or stabilization, while others lead to respiratory failure and death. Recent advances in the field have led to the approval of drugs for the treatment of specific interstitial lung diseases, including systemic sclerosis-associated interstitial lung disease, interstitial lung disease-associated pulmonary hypertension, and progressive pulmonary fibrosis.

LANCET (2022)

Article Engineering, Environmental

Bisphenol A inhibits osteogenic activity and causes bone resorption via the activation of retinoic acid-related orphan receptor α

Wisurumuni Arachchilage Hasitha Maduranga Karunarathne et al.

Summary: This study reveals that BPA inhibits osteoblast differentiation and bone formation by activating ROR alpha, potentially causing bone-resorptive diseases such as osteoporosis.

JOURNAL OF HAZARDOUS MATERIALS (2022)

Article Biochemistry & Molecular Biology

Screening for idiopathic pulmonary fibrosis using comorbidity signatures in electronic health records

Dmytro Onishchenko et al.

Summary: This study introduces a new screening tool for early diagnosis of idiopathic pulmonary fibrosis (IPF) using comorbidity signatures. The algorithm, called ZCoR-IPF, shows high accuracy and specificity in predicting the future risk of an IPF diagnosis, potentially improving outcomes of disease-modifying therapies.

NATURE MEDICINE (2022)

Review Medicine, Research & Experimental

Quercetin: A Molecule of Great Biochemical and Clinical Value and Its Beneficial Effect on Diabetes and Cancer

Aikaterini-Spyridoula Michala et al.

Summary: Quercetin is an important polyphenol with antioxidant properties that plays a positive role in oxidative stress, cancer, and blood sugar regulation. Although the specific daily intake of quercetin has not been determined, research shows that it is a valuable dietary antioxidant.

DISEASES (2022)

Article Integrative & Complementary Medicine

Acacetin inhibits invasion, migration and TGF-β1-induced EMT of gastric cancer cells through the PI3K/Akt/Snail pathway

Guangtao Zhang et al.

Summary: Acacetin inhibits proliferation, invasion, and migration of human gastric cancer cells by regulating EMT-related proteins. It reverses morphological changes induced by TGF-beta 1 and restricts invasion and migration by regulating EMT. Acacetin also suppresses PI3K/Akt signaling and delays metastasis in vivo.

BMC COMPLEMENTARY MEDICINE AND THERAPIES (2022)

Article Oncology

The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance

Bikash Chandra Jena et al.

Summary: TGF-beta is considered as a crucial mediator of cell growth and cancer cell progression through both SMAD-dependent and independent pathways. In the tumor microenvironment, cancer-associated fibroblasts (CAFs) play a prominent role in tumor progression and chemoresistance, with TGF-beta facilitating the crosstalk between CAFs and tumor cells. Targeting the TGF-beta and CAFs interaction in clinical trials is essential for developing successful anti-cancer therapies.

CANCER LETTERS (2021)

Review Chemistry, Medicinal

Molecular mechanisms of anticancer effect of rutin

Amir Imani et al.

Summary: Rutin, a polyphenolic bioflavonoid, has been extensively studied for its antioxidant properties and pharmacological applications in cancer research due to its safety and minor side effects. In-vivo and in-vitro examinations have shown that rutin regulates various cellular signaling pathways to mediate its anticancer effects, making it a promising compound for cancer treatment.

PHYTOTHERAPY RESEARCH (2021)

Review Medicine, Research & Experimental

TGF-β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review)

Zhimin Ye et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a global disease with no effective treatment currently available. Research shows that transforming growth factor-beta 1 (TGF-beta 1) plays a crucial role in the development of IPF, promoting fibrosis through various signaling pathways and affecting oxidative stress and epigenetics. Although most processes related to TGF-beta 1 promote IPF, it can also inhibit its development.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Review Oncology

Novel therapies emerging in oncology to target the TGF-β pathway

Byung-Gyu Kim et al.

Summary: The TGF-beta signaling pathway plays a crucial role in physiological cellular processes and is dysregulated in pathologies such as cancer. It can function as either a tumor promoter or a tumor suppressor, affecting processes such as cell proliferation, migration, invasion, metastasis, and immunosurveillance. Various therapeutic strategies targeting TGF-beta signaling have shown promise in preclinical studies and clinical trials, but challenges remain in balancing its tumor-promoting and tumor-suppressing activities for effective cancer treatment.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Agriculture, Multidisciplinary

In Vitro and In Vivo Study on the Toxic Effects of Propiconazole Fungicide in the Pathogenesis of Liver Fibrosis

Hyuk Cheol Kwon et al.

Summary: This study found that exposure to PCZ may induce liver fibrosis through intracellular oxidative stress and the TGF-β/Smad pathway, posing a risk to the functional integrity of the liver in humans.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)

Article Immunology

Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease

Xiao-ying Sun et al.

Summary: The study demonstrated that rutin could inhibit tau aggregation and tau oligomer-induced cytotoxicity, reduce the production of proinflammatory cytokines, protect neuronal morphology from toxic tau oligomers, and promote microglial uptake of extracellular tau oligomers. In a Tau-P301S mouse model, rutin also reduced pathological tau levels, regulated tau hyperphosphorylation, suppressed gliosis and neuroinflammation, prevented microglial synapse engulfment, and rescued synapse loss, resulting in a significant improvement of cognition. These findings suggest that rutin is a promising drug candidate for Alzheimer's disease treatment by targeting both tau and amyloid beta pathology.

JOURNAL OF NEUROINFLAMMATION (2021)

Review Biochemistry & Molecular Biology

Transit and Metabolic Pathways of Quercetin in Tubular Cells: Involvement of Its Antioxidant Properties in the Kidney

Daniel Munoz-Reyes et al.

Summary: Quercetin, a flavonoid compound with antioxidant properties, is considered to have therapeutic potential in protecting against oxidative stress, particularly in the kidney. However, the specific metabolic processes and effects in the kidney remain unclear.

ANTIOXIDANTS (2021)

Article Respiratory System

Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study

Pavo Marijic et al.

Summary: This study compared patients treated with pirfenidone and nintedanib in terms of mortality, hospitalization, and healthcare costs, finding no significant differences between the two drugs in these patient-related outcomes.

RESPIRATORY RESEARCH (2021)

Article Endocrinology & Metabolism

Anti-Cancerous Effect of Rutin Against HPV C33A Cervical Cancer Cells via G0/G1 Cell Cycle Arrest and Apoptotic Induction

Fahad Khan et al.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2020)

Review Cell Biology

TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering

Jin Ma et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

A Novel, Pan-PDE Inhibitor Exerts Anti-Fibrotic Effects in Human Lung Fibroblasts via Inhibition of TGF-β Signaling and Activation of cAMP/PKA Signaling

Katarzyna Wojcik-Pszczola et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research

Nathalie Percie du Sert et al.

PLOS BIOLOGY (2020)

Article Biochemistry & Molecular Biology

The extracellular matrix and mechanotransduction in pulmonary fibrosis

Zhenjun Deng et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2020)

Article Medicine, Research & Experimental

SB431542-Loaded Liposomes Alleviate Liver Fibrosis by Suppressing TGF-β Signaling

Jinhang Zhang et al.

MOLECULAR PHARMACEUTICS (2020)

Article Pharmacology & Pharmacy

Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice

Jizhen Huang et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Multidisciplinary Sciences

Fibrosis: from mechanisms to medicines

Neil C. Henderson et al.

NATURE (2020)

Review Cell Biology

The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders

Jacopo Di Gregorio et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Respiratory System

Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches

Daniel S. Glass et al.

RESPIRATORY INVESTIGATION (2020)

Review Biochemistry & Molecular Biology

Developmental pathways in the pathogenesis of lung fibrosis

Diptiman Chanda et al.

MOLECULAR ASPECTS OF MEDICINE (2019)

Review Medicine, General & Internal

Epithelial-Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis

Francesco Salton et al.

MEDICINA-LITHUANIA (2019)

Review Biochemistry & Molecular Biology

A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment

Linh Khanh Huynh et al.

BIOMOLECULES (2019)

Article Medicine, Research & Experimental

Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK/AP-1 pathways

Jing Wang et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Review Respiratory System

Idiopathic pulmonary fibrosis: pathogenesis and management

Giacomo Sgalla et al.

RESPIRATORY RESEARCH (2018)

Review Oncology

The extracellular matrix - the under-recognized element in lung disease?

Janette K. Burgess et al.

JOURNAL OF PATHOLOGY (2016)

Article Biochemistry & Molecular Biology

Rutin decreases lipopolysaccharide-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-κB pathway

Chung-Hsin Yeh et al.

FREE RADICAL BIOLOGY AND MEDICINE (2014)

Article Immunology

The effect of sesamin on airway fibrosis in vitro and in vivo

Ching-Huei Lin et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2014)

Article Cell Biology

Structural basis for specificity of TGFβ family receptor small molecule inhibitors

Abiodun A. Ogunjimi et al.

CELLULAR SIGNALLING (2012)

Article Neurosciences

Rutin Protects Dopaminergic Neurons from Oxidative Stress in an Animal Model of Parkinson's Disease

Mohd Moshahid Khan et al.

NEUROTOXICITY RESEARCH (2012)

Article Physiology

Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis

Elizabeth F. Redente et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)

Article Chemistry, Analytical

Sensitive voltammetric determination of rutin at an in situ plated lead film electrode

Katarzyna Tyszczuk

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)

Article Biochemistry & Molecular Biology

ALK-5 mediates endogenous and TGF-β1-induced expression of connective tissue growth factor in embryonic lung

Shu Wu et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)

Article Chemistry, Multidisciplinary

Effect of TGF-β/Smad signaling pathway on lung myofibroblast differentiation

Li Gu et al.

ACTA PHARMACOLOGICA SINICA (2007)

Article Pharmacology & Pharmacy

Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis

AC de Gouville et al.

BRITISH JOURNAL OF PHARMACOLOGY (2005)

Article Physiology

Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice

JS Zhao et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)